; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (165) Fluopyram formulations Heading 9902.09.61 is amended— (A) by amending the article description to read as follows: Mixtures of N-[2-[3-chloro-5-(trifluoromethyl) pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (166) Fluopyram and imidacloprid formulations Heading 9902.09.62 is amended— (A) by amending the article description to read as follows: Mixtures of N-[2-[3-chloro-5-(trifluoromethyl) pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl] nitramide (Imidacloprid) (CAS No. 138261–41–3) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (167) Iprodione and trifloxystrobin formulations Heading 9902.09.70 is amended— (A) by amending the article description to read as follows: Mixtures containing 3-(3,5-dichlorophenyl)-N-isopropyl-2,4-dioxo-1-imidazolidinecarboxamide (Iprodione) (CAS No. 36734–19–7) and methyl (2E)-(methoxyimino) [2-({[(E)-{1-[3-(trifluoromethyl) phenyl]ethylidene}amino]oxy}methyl)phenyl] acetate (Trifloxystrobin) (CAS No. 141517–21–7) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (168) Tetraconazole and azoxystrobin Heading 9902.09.71 is amended— (A) by amending the article description to read as follows: Mixtures of 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)-propyl]-1H-1,2,4-triazole (Tetraconazole) (CAS No. 112281–77–3), methyl (2E)-2-(2-{[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy}phenyl)-3-methoxyacrylate (Azoxystrobin) (CAS No. 131860–33–8) and application adjuvants (provided for in subheading 3808.92.15)